G20 Parkinson's disease

Add Analogs Compare

Medications used: More... hide

Pharm. gr.	Substance	Drugs
Antiparkinsonian drugs	Levodopa
	Pergolide	Permax
	Selegiline	Eldepryl \| Cognitiv \| Niar \| Segan \| Selegiline \| Jumex
	Tolcapone	Tasmar
Antiviral (with the exception of HIV) drugs	Amantadine	Midantan
Dopa and its derivatives	Levodopa+Benserazide	Бензиэль \| Levodopa+Benserazide \| Levodopa/Benserazide-Teva \| Madopar «125» \| Madopar «250» \| Madopar \| Madopar dispersible 125 \| Madopar HBS «125»
Dopa and its derivatives	Levodopa+Carbidopa	Duodopa \| Isicom \| Carbidopa/Levodopa \| Credanil \| Nakom \| Syndopa \| Sinemet \| Sinemet SR \| Tidomet forte \| Tremonorm \| Zimox
Dopamine Receptor Agonists	Piribedil	Пронокогнил \| Pronoran
	Pramipexole	Mipexole \| Mirapex \| Pramipexole \| Pramipexole-Teva
	Ropinirole	Requip Modutab \| Sindranol
	Rotigotine	Neupro
Dopaminomimetics	Ergoloid mesylates
M-, n-Cholinolytics	Aethpenalum
	Diethazine
	Diphenyltropine
Other neurotropic agents	Memantin
Prolactin inhibitors	Bromocriptine	Bromocriptine mesilate
Tertiary amines	Biperiden	Безак \| Бипериден \| Mendilex
Tertiary amines	Trihexyphenidyl	Cyclodol \| Parkoran \| Тригексифенидил-Фармстандарт

Other names and synonyms

G20.

G20 Parkinson's disease

Description

Связанные термины.

БОЛЕЗНЬ ПАРКИНСОНА.
Источник информации: Словарь терминов, используемых в психиатрии / Ю.А. Александровский. 5-е изд., перераб. и доп. М. ВЕДАНТА, 2021.

Related diseases

Related clinical guidelines

Болезнь Паркинсона, вторичный паркинсонизм и другие заболевания, проявляющиеся синдромом паркинсонизма

Related standards of medical care

✘Available only when using PRO account

Content moderator: Vasin A. S.

Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
Nothing in the information provided should be interpreted as a call to use these drugs.
No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.